Cargando…
Drug metabolism and pancreatic cancer
Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient’s individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more e...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198247/ https://www.ncbi.nlm.nih.gov/pubmed/28042238 http://dx.doi.org/10.20524/aog.2016.0074 |
_version_ | 1782488856407310336 |
---|---|
author | Flores, John Paul E. Diasio, Robert B. Saif, Muhammad Wasif |
author_facet | Flores, John Paul E. Diasio, Robert B. Saif, Muhammad Wasif |
author_sort | Flores, John Paul E. |
collection | PubMed |
description | Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient’s individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more efficacious and cost effective. This is particularly relevant for pancreatic cancer, which currently portends a very poor prognosis. However, there is much to be done in this field, and more studies are needed to bring this concept to reality. |
format | Online Article Text |
id | pubmed-5198247 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hellenic Society of Gastroenterology |
record_format | MEDLINE/PubMed |
spelling | pubmed-51982472017-01-01 Drug metabolism and pancreatic cancer Flores, John Paul E. Diasio, Robert B. Saif, Muhammad Wasif Ann Gastroenterol Review Article Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient’s individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more efficacious and cost effective. This is particularly relevant for pancreatic cancer, which currently portends a very poor prognosis. However, there is much to be done in this field, and more studies are needed to bring this concept to reality. Hellenic Society of Gastroenterology 2017 2016-07-21 /pmc/articles/PMC5198247/ /pubmed/28042238 http://dx.doi.org/10.20524/aog.2016.0074 Text en Copyright: © Hellenic Society of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Flores, John Paul E. Diasio, Robert B. Saif, Muhammad Wasif Drug metabolism and pancreatic cancer |
title | Drug metabolism and pancreatic cancer |
title_full | Drug metabolism and pancreatic cancer |
title_fullStr | Drug metabolism and pancreatic cancer |
title_full_unstemmed | Drug metabolism and pancreatic cancer |
title_short | Drug metabolism and pancreatic cancer |
title_sort | drug metabolism and pancreatic cancer |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198247/ https://www.ncbi.nlm.nih.gov/pubmed/28042238 http://dx.doi.org/10.20524/aog.2016.0074 |
work_keys_str_mv | AT floresjohnpaule drugmetabolismandpancreaticcancer AT diasiorobertb drugmetabolismandpancreaticcancer AT saifmuhammadwasif drugmetabolismandpancreaticcancer |